Abstract
Background Combining Gliadel wafers and radiochemotherapy with TMZ may carry the risk of increased adverse events (AE). We analyzed the efficacy and safety in patients with glioblastoma who underwent multimodal treatment with implantation of Gliadel wafers. Methods One hundred sixty-five consecutive patients with newly diagnosed (77 patients) or recurrent (88 patients) glioblastoma were studied. Forty-seven patients underwent surgery + Gliadel. The impact of age (≥65 vs.
Original language | English |
---|---|
Pages (from-to) | 1371-1378 |
Number of pages | 8 |
Journal | Acta Neurochirurgica |
Volume | 154 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2012 |
Keywords
- Carmustine-wafers
- Efficacy
- Gliadel
- Glioblastoma
- Safety
- Toxicity
ASJC Scopus subject areas
- Clinical Neurology
- Surgery